Significant Pharmaceutical Company definition

Significant Pharmaceutical Company is a pharmaceutical company, biotechnology company, or group of such companies acting in concert, with aggregate annual sales of pharmaceutical products greater than [**] U.S. dollars ($[**]).
Significant Pharmaceutical Company means a company that is engaged in the business of selling pharmaceutical products, whose revenues (on a consolidated basis in the last full fiscal year prior to the closing of any Change of Control) was in excess of $[…***…]. Any affiliate (as defined in Section 1.1, mutatis mutandis) of such company shall be deemed to be a Significant Pharmaceutical Company.
Significant Pharmaceutical Company means a company (a) which, together with its Affiliates, has substantial capabilities and experience in the manufacture, distribution and commercialization of pharmaceutical products for human use, and (b) which, together with its Affiliates, has development, regulatory and scientific infrastructure relevant to the CVR Products that is at least reasonably comparable to that of Parent and its Affiliates.

Examples of Significant Pharmaceutical Company in a sentence

  • Additionally, in the event of a Change in Control of Licensor in which Licensor is acquired by a Significant Pharmaceutical Company, AbbVie shall have the right, effective upon written notice, to disband the JDC pursuant to Section 13.2.1(b).

  • Xencor shall notify Amgen in writing promptly of the closing of any Change of Control of Xencor involving a Significant Pharmaceutical Company.

  • Enanta shall have the right to Co-Detail Product(s) in the United States in accordance with agreed Commercialization plans and budgets under certain preconditions as further specified below; provided that in the event of a Change of Control where the Acquirer is a Significant Pharmaceutical Company, Novartis may immediately terminate Enanta’s right to Co-Detail Products by providing written notice to Enanta.

  • In the event of a Change of Control involving a Significant Pharmaceutical Company, Novartis may immediately terminate the Co-Detailing Agreement by providing written notice to Enanta.

  • Additionally, in the event of a Change in Control of Licensor in which Licensor is acquired by a Significant Pharmaceutical Company, AbbVie shall have the right, effective upon written notice, to disband one or all Joint Committees pursuant to Section 13.2.1(b).


More Definitions of Significant Pharmaceutical Company

Significant Pharmaceutical Company has the meaning set forth in Section 13.2.1(b).
Significant Pharmaceutical Company means any company whose market capitalization of equity securities at the time of any transfer contemplated by Section 1.13(h) is an amount equal to at least $2,000,000,000.
Significant Pharmaceutical Company shall have the meaning set forth in Section 2.4(b).
Significant Pharmaceutical Company means, with respect to a given Change of Control transaction, a company in the pharmaceutical industry that, in its most recent fiscal year completed prior to the announcement of such Change of Control had annual sales in excess of [*****], as reflected in such company’s financial statements, based on the prevailing currency exchange rates in effect on the last business day of such fiscal year as quoted at Xxxxxxxxx.xxx, as relevant.
Significant Pharmaceutical Company means a pharmaceutical company, biotechnology company, or group of such companies acting in concert which is a Third Party and with a market capitalization greater than [*] as of the effective date of a Change in Control.
Significant Pharmaceutical Company means a company which, together with its Affiliates, has capabilities and experience in the development, manufacture, distribution and commercialization of pharmaceutical products that, in its most recent fiscal year completed prior to the close of the transaction pursuant to which such company obtained global rights to the Valued Product as set forth in this Section 4.3(a), had annual consolidated revenues (with its Affiliates) of at least $10 billion, as reflected in such company’s audited financial statements.
Significant Pharmaceutical Company means, with respect to a given Change of Control transaction, a company in the pharmaceutical industry that, [*****].